BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 1, 2006
View Archived Issues
Predix In Potential $307.5M Collaboration With Amgen
In its first major partnership, Predix Pharmaceuticals Holdings Inc. could receive more than $307.5 million per terms of a new deal with Amgen Inc. on S1P1 modulators for autoimmune diseases. (BioWorld Today)
Read More
YM Secures Japanese Partner For EGFR-Inhibitor In Cancer
Read More
Still Turning: Racial Profiling, Harassment, VC Execs Get Hip
Read More
Pandemic Planning: Not 'Out Of The Woods' Despite Good News
Read More
FDA Mulling Plan B OTC Sales For Those 18, Older
Read More
Opting For An LSE Listing, Napo Raises £11.9M In IPO
Read More
Receptor BioLogix Acquires Failed Aphton Cancer Drug
Read More
Other News To Note
Read More